These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 36612062)

  • 1. Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma.
    Kühnel C; Köhler A; Brachwitz T; Seifert P; Gühne F; Aschenbach R; Freudenberg R; Freesmeyer M; Drescher R
    J Pers Med; 2024 Jul; 14(7):. PubMed ID: 39064001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series.
    Vermeulen S; De Keukeleire K; Dorny N; Colle I; Van Den Bossche B; Nuttens V; Ooms D; De Bondt P; De Winter O
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Periprocedural X-ray Exposure in Transarterial Radioembolization with Glass or Resin Microspheres.
    Ehrengut C; Vogt J; Leonhardi J; Carabenciov E; Teske F; Boemmel FV; Berg T; Seehofer D; Lincke T; Sabri O; Gößmann H; Denecke T; Ebel S
    Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132193
    [No Abstract]   [Full Text] [Related]  

  • 4. Transarterial Radioembolization Agents: a Review of the Radionuclide Agents and the Carriers.
    Alrfooh A; Patel A; Laroia S
    Nucl Med Mol Imaging; 2021 Aug; 55(4):162-172. PubMed ID: 34422126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial Radioembolization (TARE) Global Practice Patterns: An International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE).
    Keane G; Lam M; Braat A; Bruijnen R; Kaufmann N; de Jong H; Smits M
    Cardiovasc Intervent Radiol; 2024 Jun; ():. PubMed ID: 38914769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments.
    Cappelli A; Pettinato C; Golfieri R
    J Hepatocell Carcinoma; 2014; 1():163-82. PubMed ID: 27508185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Radioembolization Planning and Treatment with Microspheres Containing Holmium-166: Determination of Renal and Intestinal Radionuclide Elimination, Effective Half-Life, and Regulatory Aspects.
    Kühnel C; Gühne F; Seifert P; Freudenberg R; Freesmeyer M; Drescher R
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and Intestinal Excretion of
    Drescher R; Kühnel C; Seifert P; Gühne F; Freesmeyer M
    AJR Am J Roentgenol; 2020 May; 214(5):1158-1164. PubMed ID: 32130046
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery.
    Roosen J; Westlund Gotby LEL; Arntz MJ; Fütterer JJ; Janssen MJR; Konijnenberg MW; van Wijk MWM; Overduin CG; Nijsen JFW
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4705-4715. PubMed ID: 35829749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving MRI-based dosimetry for holmium-166 transarterial radioembolization using a nonrigid image registration for voxelwise
    Roosen J; van Wijk MWM; Westlund Gotby LEL; Arntz MJ; Janssen MJR; Lobeek D; van de Maat GH; Overduin CG; Nijsen JFW
    Med Phys; 2023 Feb; 50(2):935-946. PubMed ID: 36202392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer.
    Drescher R; Köhler A; Seifert P; Aschenbach R; Ernst T; Rauchfuß F; Freesmeyer M
    Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioembolization With Holmium-166 Polylactic Acid Microspheres: Distribution of Residual Activity in the Delivery Set and Outflow Dynamics During Planning and Treatment Procedures.
    Drescher R; Seifert P; Gühne F; Aschenbach R; Kühnel C; Freesmeyer M
    J Endovasc Ther; 2021 Jun; 28(3):452-462. PubMed ID: 33629598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of radionuclide impurities in several radiopharmaceuticals].
    Freudenberg R; Hesse L; Kotzerke J
    Nuklearmedizin; 2022 Aug; 61(4):339-346. PubMed ID: 35426097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomicrosphere Dosimetry: Principles and Current State of the Art.
    Gulec SA; McGoron AJ
    Semin Nucl Med; 2022 Mar; 52(2):215-228. PubMed ID: 35148897
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.